Movement Alert｜Icon PLC Rises 10.18% in Regular Trading, Announces Multi-Year AI Partnership with Anthropic

Market Focus

Jul 28

On July 28, Icon PLC rose 10.18% in regular trading, trading at $180.37/share, with turnover of $76.95 million. The surge was driven by the announcement of a multi-year collaboration with Amazon-backed artificial intelligence company Anthropic.

Under the partnership, Icon PLC will integrate Anthropic's Claude AI platform into its clinical trial software to optimize trial site selection, monitor patient enrollment risks, and improve study designs. Financial terms were not disclosed. Notably, this agreement builds upon Icon PLC's earlier selection of Microsoft as a preferred technology partner in June, which included enterprise-wide deployment of Microsoft 365 Copilot and Azure data services to scale its agentic AI platform, Orbis. The dual AI partnerships significantly strengthen the company's positioning in clinical trial automation.

The move comes one day ahead of Icon PLC's quarterly earnings release scheduled for July 29, with consensus estimates projecting revenue of approximately $2.034 billion and adjusted EPS of $2.42. Within the Life Sciences Tools & Services sector, peer IQVIA rose 12.11% and Repligen gained 12.57% on the same session.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1190086339"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1190086339\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1190086339?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-28 22:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1190086339","market":"us","top_or_hot":-1,"title":"Movement Alert｜Icon PLC Rises 10.18% in Regular Trading, Announces Multi-Year AI Partnership with Anthropic","media":"Market Focus","content":"<p><p>On July 28, Icon PLC rose 10.18% in regular trading, trading at $180.37/share, with turnover of $76.95 million. The surge was driven by the announcement of a multi-year collaboration with Amazon-backed artificial intelligence company Anthropic.</p><p>Under the partnership, Icon PLC will integrate Anthropic's Claude AI platform into its clinical trial software to optimize trial site selection, monitor patient enrollment risks, and improve study designs. Financial terms were not disclosed. Notably, this agreement builds upon Icon PLC's earlier selection of Microsoft as a preferred technology partner in June, which included enterprise-wide deployment of Microsoft 365 Copilot and Azure data services to scale its agentic AI platform, Orbis. The dual AI partnerships significantly strengthen the company's positioning in clinical trial automation.</p><p>The move comes one day ahead of Icon PLC's quarterly earnings release scheduled for July 29, with consensus estimates projecting revenue of approximately $2.034 billion and adjusted EPS of $2.42. Within the Life Sciences Tools &amp; Services sector, peer IQVIA rose 12.11% and Repligen gained 12.57% on the same session.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Icon PLC Rises 10.18% in Regular Trading, Announces Multi-Year AI Partnership with Anthropic</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Icon PLC Rises 10.18% in Regular Trading, Announces Multi-Year AI Partnership with Anthropic\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-28 22:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 28, Icon PLC rose 10.18% in regular trading, trading at $180.37/share, with turnover of $76.95 million. The surge was driven by the announcement of a multi-year collaboration with Amazon-backed artificial intelligence company Anthropic.</p><p>Under the partnership, Icon PLC will integrate Anthropic's Claude AI platform into its clinical trial software to optimize trial site selection, monitor patient enrollment risks, and improve study designs. Financial terms were not disclosed. Notably, this agreement builds upon Icon PLC's earlier selection of Microsoft as a preferred technology partner in June, which included enterprise-wide deployment of Microsoft 365 Copilot and Azure data services to scale its agentic AI platform, Orbis. The dual AI partnerships significantly strengthen the company's positioning in clinical trial automation.</p><p>The move comes one day ahead of Icon PLC's quarterly earnings release scheduled for July 29, with consensus estimates projecting revenue of approximately $2.034 billion and adjusted EPS of $2.42. Within the Life Sciences Tools &amp; Services sector, peer IQVIA rose 12.11% and Repligen gained 12.57% on the same session.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ICLR","symbol_name":"ICON plc","start_time":0,"source_url":"","article_id":"1190086339","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1190086339","pubTimestamp":1785249335,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 28, Icon PLC rose 10.18% in regular trading, trading at $180.37/share, with turnover of $76.95 million. The surge was driven by the announcement of a multi-year collaboration with...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ICLR":"ICON plc"},"translate_title":"走势警报|Icon PLC 常规交易上涨 10.18%，宣布与 Anthropic 建立多年人工智能合作伙伴关系","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ICLR":1},"content_text":"On July 28, Icon PLC rose 10.18% in regular trading, trading at $180.37/share, with turnover of $76.95 million. The surge was driven by the announcement of a multi-year collaboration with Amazon-backed artificial intelligence company Anthropic.Under the partnership, Icon PLC will integrate Anthropic's Claude AI platform into its clinical trial software to optimize trial site selection, monitor patient enrollment risks, and improve study designs. Financial terms were not disclosed. Notably, this agreement builds upon Icon PLC's earlier selection of Microsoft as a preferred technology partner in June, which included enterprise-wide deployment of Microsoft 365 Copilot and Azure data services to scale its agentic AI platform, Orbis. The dual AI partnerships significantly strengthen the company's positioning in clinical trial automation.The move comes one day ahead of Icon PLC's quarterly earnings release scheduled for July 29, with consensus estimates projecting revenue of approximately $2.034 billion and adjusted EPS of $2.42. Within the Life Sciences Tools & Services sector, peer IQVIA rose 12.11% and Repligen gained 12.57% on the same session.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}